Related Experiment Video
Updated: Jun 22, 2026
11:18
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
Thoracic oncology multidisciplinary teams: between the promises and challenges
Abdul-Rahman Jazieh1, Abdulrahman Al Hadab, John Howington
1Department of Oncology, King Abdul-Aziz Medical City, King Fahad National Guard Hospital, Saudi Arabia. jazieha@ngha.med.sa
Annals of Thoracic Medicine
|June 30, 2009
Summary
Thoracic oncology multidisciplinary teams improve patient care for thoracic malignancies. Understanding their roles and challenges is key to maximizing their potential in healthcare.
Area of Science:
- Oncology
- Healthcare Management
- Team-Based Care
Background:
- Multidisciplinary teams are increasingly vital in managing thoracic malignancies.
- These teams offer significant potential to enhance patient care and healthcare systems.
- Despite their benefits, thoracic oncology multidisciplinary teams face numerous challenges.
Purpose of the Study:
- To explore the functions, roles, benefits, and challenges of thoracic oncology multidisciplinary teams.
- To foster a comprehensive understanding among team members and leadership.
- To identify strategies for optimizing the effectiveness of these teams.
Main Methods:
- Literature review on multidisciplinary team functions in thoracic oncology.
- Analysis of reported benefits and challenges in team-based cancer care.
- Synthesis of perspectives from team members and leadership.
Main Results:
- Thoracic oncology multidisciplinary teams play a growing role in cancer management.
- Potential exists for improved patient outcomes and healthcare efficiency.
- Significant challenges impede the full realization of team potential.
Conclusions:
- A deeper understanding of team dynamics is crucial for success.
- Addressing identified challenges is necessary to leverage team benefits.
- Further research should focus on optimizing multidisciplinary team performance in thoracic oncology.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...